September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Clinical evaluation of ultra high field MRI for three-dimensional visualization of tumour size in uveal melanoma patients, with direct relevance to treatment planning
Author Affiliations & Notes
  • Jan-Willem Beenakker
    Department of Ophthalmology, Leiden University Medical Center, Leiden, Netherlands
    Department of Radiology, C.J. Gorter Center for High-field MRI, Leiden University Medical Center, Leiden, Netherlands
  • Teresa Ferreira
    Department of Radiology, Leiden University Medical Center, Leiden, Netherlands
  • Karina Soemarwoto
    Department of Radiology, C.J. Gorter Center for High-field MRI, Leiden University Medical Center, Leiden, Netherlands
  • Stijn Genders
    Department of Ophthalmology, Leiden University Medical Center, Leiden, Netherlands
  • Wouter Teeuwisse
    Department of Radiology, C.J. Gorter Center for High-field MRI, Leiden University Medical Center, Leiden, Netherlands
  • Andrew Webb
    Department of Radiology, C.J. Gorter Center for High-field MRI, Leiden University Medical Center, Leiden, Netherlands
  • Gregorius P. M. Luyten
    Department of Ophthalmology, Leiden University Medical Center, Leiden, Netherlands
  • Footnotes
    Commercial Relationships   Jan-Willem Beenakker, None; Teresa Ferreira, None; Karina Soemarwoto, None; Stijn Genders, None; Wouter Teeuwisse, None; Andrew Webb, None; Gregorius P. Luyten, None
  • Footnotes
    Support  Landelijke Stichting Blinden en Slechtzienden, Utrecht, The Netherlands
Investigative Ophthalmology & Visual Science September 2016, Vol.57, No Pagination Specified. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Jan-Willem Beenakker, Teresa Ferreira, Karina Soemarwoto, Stijn Genders, Wouter Teeuwisse, Andrew Webb, Gregorius P. M. Luyten; Clinical evaluation of ultra high field MRI for three-dimensional visualization of tumour size in uveal melanoma patients, with direct relevance to treatment planning. Invest. Ophthalmol. Vis. Sci. 201657(12):.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Uveal melanoma (UM) is the most common primary intraocular malignant tumour. The optimal treatment is mainly determined by the location and size of the tumour, which is presently measured with 2D ultrasound. Recent advances in ocular MRI make it possible to image the complete tumour in 3D. In this work we assess the tumour dimensions in UM patients using high-resolution ocular MRI, and we compare these values with ultrasound in order to provide improved information for treatment options.

Methods : 10 UM patients were examined on a 7Tesla MRI using a custom-built eye-coil and dedicated 3D scan sequences to minimize eye-motion-induced image artifacts. A 3D assessment of the tumour was performed to determine the maximum tumour prominence and compared with the standard clinical evaluation from 2D ultrasound images.

Results : The MRI resulted in motion-free images of the eye in which the tumour and surrounding tissues could clearly be discriminated. For 8 of 10 patients the MRI showed a slightly different value of tumour prominence (average 1.0 mm difference) than the ultrasound. For large, complexely shaped, tumours (>10mm) the MRI showed a larger maximal tumour prominence, whereas for the medium sized tumours the MRI resulted in smaller values than the ultrasound. This can be attributed to the oblique cuts made by the ultrasound which overestimate the tumour size. For two of these patients the more accurate results from the MR-images changed the treatment plan, with the smaller tumour dimensions making them eligible for eye-preserving therapy.

Conclusions : High-resolution ocular MRI can yield a more accurate measurement of the tumour dimensions than conventional ultrasound, which can result in significant changes in the prescribed treatment.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

 

Representative images from 3 patients. (A,D,G) clinical ultrasound measurements showing the tumour prominence. (B,E,H) High-resolution 3D MR-images (using a 3D MPRAGE sequence) in which the tumour prominence is measured. (C,F,I) Additional 2D TSE-images acquired perpendicular to the tumour.

Representative images from 3 patients. (A,D,G) clinical ultrasound measurements showing the tumour prominence. (B,E,H) High-resolution 3D MR-images (using a 3D MPRAGE sequence) in which the tumour prominence is measured. (C,F,I) Additional 2D TSE-images acquired perpendicular to the tumour.

 

Comparison between ultrasound and MRI measurements of the tumour prominence of 10 UM patients. In 5 of these patients the 3D MRI evaluation revealed a smaller tumour compared to the 2D ultrasound images. In the 3 patients with a large and complexly shaped tumour, the MRI showed a larger tumour prominence.

Comparison between ultrasound and MRI measurements of the tumour prominence of 10 UM patients. In 5 of these patients the 3D MRI evaluation revealed a smaller tumour compared to the 2D ultrasound images. In the 3 patients with a large and complexly shaped tumour, the MRI showed a larger tumour prominence.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×